Green Pyramid was featured in “The Pune Mirror “

Venture Center’s resident incubatee “Green Pyramid Biotech Pvt Ltd” was featured in “The Pune Mirror “ in an article named “A CLEAN-UP FOR YOUR VEGGIES”

The article describes the need of the type of product developed by the company in the market and also showcased the requirement of targeted research activities in India.

Further details about the article can be found here:

Nishant Kumar of Embryyo Technologies is one among “Top 10 Innovators Under 35” from India.

Mint, the financial daily from the stable of HT Media Ltd, and MIT Technology Review, published by the Massachusetts Institute of Technology (MIT), teamed up to identify the ‘Top 10 Innovators Under 35’ from India. Nishant Kumar -co-founder of Embryyo Technologies Pvt Ltd , a resident incubatee of Venture Center is one among the top ten innovators.

The 10 candidates were chosen from hundreds of applicants from areas like biomedicine, computing, communications, health, education, digital, energy, materials, cybersecurity, fintech, wearables, robotics, education and transportation. The 10 winners from India automatically qualify for the TR35 global competition.


OmiX Labs invited to the Pitch@Rashtrapati Bhavan

Venture Center’s associate incubatee startup “Omix Labs & Diagnostics Research Center” was one of 30+ companies invited to the Pitch@Rashtrapati Bhavan on March 7, 2017.

The event was organized by the President’s office as part of a week being celebrated at Rashtrapati Bhavan as “Festival of Innovation”. The startup companies had the opportunity to interact with a dozen Venture Capital firms that were also invited to the event and to present their company and were felicitated by the President of India. Also in attendance were the Minister of Skills Development and Entrepreneurship and the CEO of Niti Aayog.

OmiX Labs was nominated and partnered by Villgro to this event.

CSIR labs NCL and IGIB sign Licensing agreement with Ahammune Biosciences for Vitiligo drug development

CSIR-National Chemical Laboratory (CSIR-NCL), Pune and CSIR- Institute of Genomics and Integrative Biology (CSIR-IGIB), New Delhi together signed a Patent Licensing agreement with Ahammune Biosciences Pvt. Ltd., Pune for Vitiligo drug development on March 2, 2017. Ahammune is a resident incubatee company of Venture Center.

Ahammune Biosciences is an innovation-led drug discovery start-up company with the vision to find a new drug for the debilitating skin disorder, Vitiligo. It is the most common depigmenting disease with over 80 million people affected by it.